MELCAYA SURVEY: Help Shape the Future of Melanoma Diagnosis

As part of the EU-funded MELCAYA project, the Digital Prevention, Diagnostics and Therapy Guidance Division at the German Cancer Research Center (DKFZ) is developing an innovative AI-based tool to improve the diagnosis of melanoma.

To ensure this technology meets the needs of patients and professionals alike, DKFZ is conducting targeted surveys to better understand the perspectives, concerns and expectations of different stakeholders. Your voice can directly influence the development of more precise, patient-centered diagnostic tools.

Why is your freedback vital?

• Share your perspective on melanoma and AI in healthcare
• Help guide ethical and practical approaches to cancer diagnostics
• Get the chance to be acknowledged as a PubMed-indexed collaborator in resulting scientific publications

 The survey is anonymous, takes about 20 minutes, and requires no prior knowledge.

Surveys are now open for the following groups: